Back to the main directory
Company Analysis / Equity
- Morningstar | Wynn Macau Company Report by Morningstar
- We're Maintaining Our Chipmaker FVEs, as We Don't Yet Foresee a Tech Cold War Despite the Huawei Ban by Morningstar
- Morningstar | Palo Alto Networks Is Our Top Cybersecurity Pick and Added to the Best Ideas List by Morningstar
- Burlington's Profitability Guidance Underwhelms as Year Closes, but Outlook Remains; Shares Rich by Morningstar
- Morningstar | Lower Interest Rates Positive for Hotel Property but Key FVE Driver is 2021 Lease Renewals by Morningstar
- Linton Out as CEO, but We See No Change to Canopy’s Strategy; Shares Look Undervalued by Morningstar
- We're Maintaining Our Chipmaker FVEs, as We Don't Yet Foresee a Tech Cold War Despite the Huawei Ban by Morningstar
- Reliance Downgrades 2019 Guidance on Softer Than Anticipated Sales Globally; Updated by Morningstar
- Morningstar | No-Moat Prologis Purchases Industrial Property Trust; Raising FVE to $77 by Morningstar
- Align's 1Q Results Show Robust Clear Aligner Growth Despite Retail Closures by Morningstar
- Morningstar | No Surprises in AngloGold Ashanti's 1Q; We See Limited Risk-Adjusted Upside by Morningstar
- Morningstar | Applied Materials’ Near-Term Prospects Remain Paralyzed by Weak Memory Spending; No Change to FVE. See Updated Analyst Note from 16 May 2019 by Morningstar
- Morningstar | Outlook Takes Shine Off Avnet’s Otherwise Decent Quarter; Maintaining $45 FVE by Morningstar
- Morningstar | Jury Awards Over $2B in Damages Against Bayer in Glyphosate Case, but Lower Costs Likely on Appeal by Morningstar
- Morningstar | Coach’s Brand Power Provides a Narrow Moat for Tapestry as It Develops a House of Upscale Brands by Morningstar
- Morningstar | Costco Should Be Able to Stem the Competitive Tide That Is Roiling Retail, but Shares Seem Rich by Morningstar
- Dentsply Is a Leading Dental Supplier, but Industry Headwinds Place the Firm on Unstable Ground by Morningstar
- Morningstar | DowDuPont Completes Corteva Spin-Off and Renames Itself DuPont; Our Fair Value Estimate Is $93. See Updated Analyst Note from 03 Jun 2019 by Morningstar
- Morningstar | Raising Our Ecolab FVE to $180 as Rising Fresh Water Costs Boost Industrial Water Treatment Profits by Morningstar
- Morningstar | Fastenal's Impressive Growth Continues in 1Q; FVE Raised to $62. See Updated Analyst Note from 11 Apr 2019 by Morningstar
- Morningstar | ITT Should Remain on Cruise Control, but Consensus Needs to Pump the Brakes on Expectations. See Updated Analyst Note from 09 Jul 2019 by Morningstar
- Morningstar | Intuitive Maintains Strong Procedure Growth in 1Q, but System Sales, Predictably, Decelerate by Morningstar
- Morningstar | Kyocera’s Plan to Improve Shareholder Return Is Positive, Raising Our FVE by Morningstar
- Lowering Our Pharmaceutical Distributor Moats, Trends, and FVEs Across the Board by Morningstar
- PG&E Earnings Grow, but Costs Weigh Heavily; Stock Still Overvalued by Morningstar